Professor | Junfen Xu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Junfen Xu
Contact Information	xjfzu@zju.edu.cn
Language ability	Chinese, English
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Junfen Xu

Contact Information

xjfzu@zju.edu.cn

Language ability

Chinese, English

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Medical
Academic Background & Achievements	2014 PhD in Obstetrics and Gynecology: Zhejiang University Visiting Scholar: National Cancer Institute (NCI), NIH, USA Zhejiang Province Medical New Star Zhejiang University Clinical Top Young Talent
Work Experience	Current - Zhejiang University School of Medicine - Associate Professor, Associate Chief Physician, Doctoral Supervisor Current - Zhejiang University School of Medicine - Deputy Director of Gynecologic Oncology Department Current - Zhejiang University School of Medicine - Deputy Director of Graduate Education Office Current - Changshan County Maternal and Child Health Hospital - Deputy Director
Awards	Zhejiang Province Medical New Star (2021): Provincial Level Invention Patent (2022): A composite nano-drug of olaparib and gallium and its preparation method and application Invention Patent (2022): A gynecological drug delivery device Zhejiang University Clinical Top Young Talent B Class Cultivation Project (2018): University Level Zhejiang University Excellent Undergraduate Class Advisor (2021): University Level

University/Lab Affiliation and Title

Zhejiang University

Faculty

Medical

Academic Background & Achievements

2014 PhD in Obstetrics and Gynecology: Zhejiang University
Visiting Scholar: National Cancer Institute (NCI), NIH, USA
Zhejiang Province Medical New Star
Zhejiang University Clinical Top Young Talent

Work Experience

Current - Zhejiang University School of Medicine - Associate Professor, Associate Chief Physician, Doctoral Supervisor
Current - Zhejiang University School of Medicine - Deputy Director of Gynecologic Oncology Department
Current - Zhejiang University School of Medicine - Deputy Director of Graduate Education Office
Current - Changshan County Maternal and Child Health Hospital - Deputy Director

Awards

Zhejiang Province Medical New Star (2021): Provincial Level
Invention Patent (2022): A composite nano-drug of olaparib and gallium and its preparation method and application
Invention Patent (2022): A gynecological drug delivery device
Zhejiang University Clinical Top Young Talent B Class Cultivation Project (2018): University Level
Zhejiang University Excellent Undergraduate Class Advisor (2021): University Level

Areas of Focus	Ovarian cancer metastasis and drug resistance Molecular targeted therapy, immunotherapy, and combination therapy for ovarian cancer Early warning and evaluation models for ovarian cancer and clinical translation
Publications	Breaking the Iron Homeostasis: A “Trojan Horse” Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition, Yangyang Li, Yixuan Cen, Yifeng Fang, Sangsang Tang, Sen Li, Yan Ren, Hongbo Zhang, Weiguo Lu, Junfen Xu, 2022 Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer, Junfen Xu, Yifeng Fang, Kelie Chen, Sen Li, Sangsang Tang, Yan Ren, Yixuan Cen, Weidong Fei, Bo Zhang, Yuanming Shen, Weiguo Lu, 2022 Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer, Yixuan Cen, Yifeng Fang, Yan Ren, Shiyuan Hong, Weiguo Lu, Junfen Xu, 2022 Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1, Haibin Liu, Junfen Xu, Yanqin Yang, Xiaohong Wang, Ethan Wu, Vladimir Majerciak, Tingting Zhang, Renske D M Steenbergen, Hsu-Kun Wang, Nilam S Banerjee, Yang Li, Weiguo Lu, Craig Meyers, Jun Zhu, Xing Xie, Louise T Chow, Zhi-Ming Zheng, 2021 Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer, Junfen Xu, Yang Li, Fenfen Wang, Bei Cheng, Feng Ye, Xing Xie, Caiyun Zhou, Weiguo Lu, 2013

Areas of Focus

Ovarian cancer metastasis and drug resistance
Molecular targeted therapy, immunotherapy, and combination therapy for ovarian cancer
Early warning and evaluation models for ovarian cancer and clinical translation

Publications

Breaking the Iron Homeostasis: A “Trojan Horse” Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition, Yangyang Li, Yixuan Cen, Yifeng Fang, Sangsang Tang, Sen Li, Yan Ren, Hongbo Zhang, Weiguo Lu, Junfen Xu, 2022
Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer, Junfen Xu, Yifeng Fang, Kelie Chen, Sen Li, Sangsang Tang, Yan Ren, Yixuan Cen, Weidong Fei, Bo Zhang, Yuanming Shen, Weiguo Lu, 2022
Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer, Yixuan Cen, Yifeng Fang, Yan Ren, Shiyuan Hong, Weiguo Lu, Junfen Xu, 2022
Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1, Haibin Liu, Junfen Xu, Yanqin Yang, Xiaohong Wang, Ethan Wu, Vladimir Majerciak, Tingting Zhang, Renske D M Steenbergen, Hsu-Kun Wang, Nilam S Banerjee, Yang Li, Weiguo Lu, Craig Meyers, Jun Zhu, Xing Xie, Louise T Chow, Zhi-Ming Zheng, 2021
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer, Junfen Xu, Yang Li, Fenfen Wang, Bei Cheng, Feng Ye, Xing Xie, Caiyun Zhou, Weiguo Lu, 2013

Ovarian Cancer Metastasis Drug Resistance Molecular Targeted Therapy Immunotherapy Combination Therapy Early Warning Evaluation Models Clinical Translation Tumor Microenvironment

Jianya Zhou - Zhejiang University

Jun Jie Xu - Zhejiang University

Jian Hu - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us